Graphene acid quantum dots: A highly active multifunctional carbon nano material that intervene in the trajectory towards neurodegeneration

• Published in: Journal of colloid and interface science 2024-09, Vol.670, p.357-363
• Main Authors: ElMorsy, Sherin M., Gutierrez, Denisse A, Valdez, Salvador, Kumar, Jyotish, Aguilera, Renato J, Noufal, Mohamed, Sarma, Hemen, Chinnam, Sampath, Narayan, Mahesh
• Format: Article
• Language: English
• Subjects: Amyloid fibrils; Animals; Apoptosis - drug effects; Biological imaging; Carbon - chemistry; Carbon nanomaterials; Cell Line, Tumor; Graphene acid quantum dots; Graphite - chemistry; Graphite - pharmacology; Humans; Membrane Potential, Mitochondrial - drug effects; Muramidase - chemistry; Muramidase - metabolism; Neurodegenerative Diseases - drug therapy; Neurodegenerative Diseases - metabolism; Neuroprotective Agents - chemistry; Neuroprotective Agents - pharmacology; Parkinson’s disease; Particle Size; Quantum Dots - chemistry; Reactive oxygen species; Reactive Oxygen Species - metabolism; Surface Properties
• ISSN: 0021-9797; 1095-7103; 1095-7103
• DOI: 10.1016/j.jcis.2024.05.072

[Display omitted] Carbon dots (CDs) are carbon nano materials (CNMs) that find use across several biological applications because of their water solubility, biocompatible nature, eco-friendliness, and ease of synthesis. Additionally, their physiochemical properties can be chemically tuned for further optimization towards specific applications. Here, we investigate the efficacy of C70-derived Graphene Acid Quantum Dots (GAQDs) in mitigating the transformation of soluble, monomeric Hen Egg-White Lysozyme (HEWL) to mature fibrils during its amyloidogenic trajectory. Our findings reveal that GAQDs exhibit dose-dependent inhibition of HEWL fibril formation (up to 70 % at 5 mg/mL) without affecting mitochondrial membrane potential or inducing apoptosis at the same density. Furthermore, GAQDs scavenged reactive oxygen species (ROS); achieving a 50 % reduction in ROS levels at a mere 100 µg/mL when exposed to a standard free radical generator. GAQDs were not only found to be biocompatible with a human neuroblastoma-derived SHSY-5Y cell line but also rescued the cells from rotenone-induced apoptosis. The GAQD-tolerance of SHSY-5Y cells coupled with their ability to restitute cells from rotenone-dependent apoptosis, when taken in conjunction with the biocompatibility data, indicate that GAQDs possess neuroprotective potential. The data position this class of CNMs as promising candidates for resolving aberrant cellular outputs that associate with the advent and progress of multifactorial neurodegenerative disorders including Parkinson’s (PD) and Alzheimer’s diseases (AD) wherein environmental causes are implicated (95 % etiology). The data suggest that GAQDs are a multifunctional carbon-based sustainable nano-platform at the intersection of nanotechnology and neuroprotection for advancing green chemistry-derived, sustainable healthcare solutions.